Display Settings:

Format

Send to:

Choose Destination
    Br J Gen Pract. 2011 Sep;61(590):e573-8.

    Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis.

    Source

    Bond University, Gold Coast, QLD, Australia. kmugunth@bond.edu.au

    Abstract

    BACKGROUND:

    Long-term use of benzodiazepines (BZDs) is common. Not only is such use ineffective, but it also has several risks in addition to dependence, and remains a significant problem among the older population.

    AIM:

    To systematically review randomised controlled trials that evaluate the effectiveness of minimal interventions to reduce the long-term use of BZDs in primary care.

    DESIGN AND SETTING:

    Systematic review and meta-analysis of randomised controlled trials in UK general practices.

    METHOD:

    Cochrane Central, MEDLINE, and Embase (1967-2010) were searched for trials of minimal interventions (such as a single letter or one consultation from a GP) for patients in primary care with long-term (>3 months) BZD use. Pooled risk differences were calculated with 95% confidence intervals.

    RESULTS:

    From 646 potentially relevant abstracts, three studies (615 patients) met all the inclusion criteria. The pooled risk ratio showed a significant reduction/cessation in BZD consumption in the minimal intervention groups compared to usual care (risk ratio [RR] = 2.1, 95% confidence interval [CI] = 1.5 to 2.9, P<0.001; RR = 2.4, 95% CI = 1.3 to 4.3, P = 0.008) respectively. Two studies also reported a significant proportional reduction in consumption of BZD from baseline to 6 months in intervention groups compared to the control group. The secondary outcome of general health status was measured in two studies; both showed a significant improvement in the intervention group.

    CONCLUSION:

    A brief intervention in the form of either a letter or a single consultation by GPs, for long-term users of BZD, is an effective and efficient strategy to decrease or stop their medication, without causing adverse consequences.

    PMID:
    22152740
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3162180
    [Available on 2012/9/1]

      Supplemental Content

      Icon for Ingenta plc

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk